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Reply from the Author
I thank Professors Kashtan and Rizzoni and Dr. Mas-
sella for their comments. They rightly point out the value
of immunostaining of renal biopsies for the diagnosis of
X-linked and autosomal Alport syndrome and the utility
of skin immunofluorescence in diagnosis of many cases
of X-linked Alport syndrome. The use of confocal laser
scanning microscopy (CLSM) [1–3] is an elegant tech-
nique to improve the spatial resolution of a5(IV) chain
distribution in basement membranes.
Ueda et al [3], also using CLSM, have reported that
compared with a2(IV), a5(IV) expression in GBM is re-
duced in patients with TBMD. The reduction in a5(IV)
but not a3(IV) and a4(IV) is difficult to reconcile with
the genetic evidence implicating mutations of COL4A3
and COL4A4 in TBMD.
Confirmation and clarification of the results of CLSM
of EBM and GBM is eagerly awaited. Until sequenc-
ing of the relevant collagen genes or other comprehen-
sive genetic testing is routinely and readily available, im-
munofluorescence of skin biopsies is a minimally invasive
means for diagnosis of many cases of X-linked Alport syn-
drome. If quantitative comparisons of the different a(IV)
chains in GBM permit a positive diagnosis of TBMD, this
will further strengthen our diagnostic hand.
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Dialysis dose and gender: A
different hypothesis
To the Editor: A recent report [1] suggested that fe-
males who are smaller than males need higher dialysis
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Fig. 1. Illustration of three relationships discriminating the high (upper
symbols) and low (lower symbols) Kt/V groups for males (solid circles)
and females (open squares) in the HEMO study. The relationships are
1) Kt = 1.16 V (thin black line) representing the low dose HEMO
study Kt/V for both genders, 2) Kt = 30 + 0.5 V (thick black line), and
3) 35 + 0.3 V (thick gray line).
dose (Kt/V) than males. The idea that smaller persons re-
quire higher Kt per L of V is not new [2], and suggests that
a 0-intercept rule for judging Kt per unit of V is incorrect
[3].
Figure 1 illustrates a non-0 intercept rule (thick black
line: Kt = 30 + 0.5 V) [3]. The mean Kt ± SD (Table 3) [1]
is shown for females (squares) and males (circles) at the
mean V (Table 2) [1] for the high (upper symbols) and
low (lower symbols) hemodialysis (HEMO) treatment
groups. The steep, thin black line is a 0-intercept Kt/V
rule (Kt = 0 + 1.16 V) [1]. All groups were treated at or
above the Kt for their V by that rule. Females in the low
treatment group (Kt = 38.2; eKt/V = 1.17), however, had
marginally worse (P = 0.02) survival than females in the
high treatment group [1].
The gray line (Kt = 35 + 0.3 V) is a rotation of the ear-
lier black line [3], and better discriminates among groups
according to outcome. Only low Kt/V females received
substantially suboptimal therapy according to this illus-
trative rule.
The point of this exercise was not to recommend a new
rule for judging treatment. It only shows that one need not
resort to speculations about different uremic toxin gen-
eration in males and females [1] to explain this marginal
survival difference. All one needs to do is accept the pos-
sibility that a 0-intercept Kt/V rule may be suboptimal.
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